Converting Oral Morphine to Transdermal Fentanyl Patch

Introduction to Conversion

The National Comprehensive Cancer Network recommends using a conversion ratio of 2:1 (oral morphine mg/day to fentanyl mcg/hour) when converting patients to transdermal fentanyl patches, selecting the appropriate patch strength based on the patient's total 24-hour oral morphine dose from standardized conversion tables 1, 2

The National Comprehensive Cancer Network guidelines suggest adding up all oral morphine taken in 24 hours, including both scheduled and breakthrough doses, to calculate the total daily oral morphine dose 1, 2
Ensure pain is relatively well-controlled before initiating the patch, as fentanyl patches are not appropriate for unstable pain requiring frequent dose adjustments 3

Provide immediate-release morphine or other short-acting opioid at 10-20% of the total daily dose for breakthrough pain 1, 2
Breakthrough medication is essential during the first 8-24 hours as fentanyl levels continue rising to steady state 1

Standard patch duration is 72 hours 3, 1
Increase patch dosage based on average daily breakthrough medication requirements after at least 2-3 days at steady state 1, 2

Only use fentanyl patches in opioid-tolerant patients to prevent fatal respiratory depression 3
Never apply heat sources (heating pads, electric blankets, heat lamps) to patch sites 3

When converting from oral morphine that provided inadequate pain relief, use 100% of the equianalgesic dose or increase by 25% rather than reducing the dose 1, 2
The conversion ratios in the tables already account for cross-tolerance, so no additional dose reduction is needed when using these specific tables 1, 2

The National Comprehensive Cancer Network guidelines recommend using clinical judgment for dose titration of fentanyl patches, as patient variability requires individualized approaches 4, 5
For normal weight patients, standard conversion tables can be followed directly for initial dosing, using the 24-hour opioid requirement to select the appropriate patch strength 4, 5

For cachectic patients, the National Comprehensive Cancer Network guidelines suggest starting with standard equianalgesic conversion tables, but anticipate the need for 25-50% higher patch doses due to impaired absorption, and monitor closely at 48-72 hours 4
The American College of Clinical Pharmacology does not provide specific guidance, but it is recommended to consider more frequent patch changes (every 48 hours) if pain control wanes in cachectic patients 6

Heat application is absolutely contraindicated, as it accelerates transdermal absorption and can cause fatal overdose, according to the National Comprehensive Cancer Network guidelines 4, 5, 6
Fentanyl patches should only be used in opioid-tolerant patients to reduce respiratory depression risk, as recommended by the National Comprehensive Cancer Network and Praxis Medical Insights 6
Breakthrough medication must be prescribed and available, particularly during the first 8-24 hours after patch application, as fentanyl levels continue rising during this period, according to the National Comprehensive Cancer Network guidelines 4, 5, 6